Utfall av byte till bevacizumab efter initial behandling med aflibercept mot åldersrelaterad makuladegeneration
Introduction Age-related macular degeneration (AMD) is an eye disease that can cause severe vision loss. At present there is no curative treatment. However, anti-vascular endothelial growth factor (VEGF) can slow down the process and prevent blindness. Ranibizumab and aflibercept are registered anti...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | Swedish |
| Published: |
Örebro universitet, Institutionen för medicinska vetenskaper
2020
|
| Subjects: | |
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-85891 |